|Articles|April 1, 2020
- Pharmaceutical Executive-04-01-2020
- Volume 40
- Issue 4
Pharmaceutical Executive, April 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
HBA's Woman of the Year 2020: A Motivated Missionover 5 years ago
Doubling Down on D&Ialmost 6 years ago
COVID-19 Ripple Effects for Pharmaalmost 6 years ago
Prescribing Patterns: How to Get Ahead of the Trendsalmost 6 years ago
There’s No Easing the Price-vs.-Value Debatealmost 6 years ago
Payer Perspectives on Gene Therapy Reimbursementalmost 6 years ago
Covid-19 Pandemic Thrusts Biopharma R&D to Forefrontalmost 6 years ago
Transforming the CIO Role to Embrace Digital Healthalmost 6 years ago
Country Report: The Czech RepublicNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
2
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
3
JP Morgan 2026: AbbVie Advances its Pipeline
4
President Trump Asks Congress to Enact 'The Great Healthcare Plan:' Report
5
